Le Lézard
Classified in: Health, Covid-19 virus
Subject: CSR

PHBS Alumni Donate COVID-19 Test Kits to UK Hospitals


Shenzhen, China, March 26, 2020 /PRNewswire/ -- Threatened by the novel coronavirus (COVID-19) epidemic, the whole world is in urgent need of medical supplies to take preventive measures and to diagnose patients who have contracted the virus. Eleven board members of Peking University HSBC Business School (PHBS) UK Campus shipped 10,000 test kits from China to Guy's and St Thomas' NHS Foundation Trust in London, UK on March 23. These newly developed test kits can diagnose the coronavirus within 15 minutes.

Guy's and St Thomas' NHS Foundation Trust is known worldwide for medical breakthroughs and innovation, and their hospitals have a long history. Guy's Hospital and St Thomas' Hospital are among the designated medical facilities which have been receiving and treating confirmed coronavirus patients in the UK.

Blessing from Peking University HSBC Business School

With "One World, One Fight" labeled on the test kit shipping boxes, the donations are showing that the UK is not fighting the coronavirus crisis alone, and we will support and help each other to win the battle.

Test kits and shipping boxes

This donation also received support from HM Revenue and UK Customs, King's College London (KCL), as well as Peking University Alumni Association in the UK, demonstrating the longstanding friendship between Peking University (PKU) and United Kingdom.

David Lawson, chief of procurement, will accept the donation on behalf of Guy's and St Thomas' NHS Foundation Trust and academic health leaders of King's Health Partners, an academic health science center based in London.

Donors are as follows (surname in alphabetical order):

SOURCE Peking University HSBC Business School


These press releases may also interest you

at 11:23
Today, Samaritan's Purse deployed its Emergency Field Hospital to New York City, New York, where the local medical infrastructure is severely overwhelmed. In cooperation with the Federal Emergency Management Agency (FEMA), New York state officials,...

at 11:01
Novartis today announced results from a prespecified analysis of pooled data from three Phase III studies evaluating the safety and efficacy of inclisiran, its first-in-class investigational treatment for hyperlipidemia in adults. The data was...

at 11:00
As the impact of the Coronavirus (COVID-19) is now felt worldwide, we want to assure our customers and partners that we are still here to support you. Zenner's operations remain open with regular operating hours. Zenner's number one priority is...

at 10:13
The Janssen Pharmaceutical Companies of Johnson & Johnson today announced the VOYAGER PAD study met its primary efficacy and principal safety endpoints, demonstrating the XARELTO® (rivaroxaban) vascular dose (2.5 mg twice daily) plus aspirin (100 mg...

at 10:05
Merck , known as MSD outside the United States and Canada, today announced the presentation of results from the VICTORIA trial, a Phase 3 study evaluating the efficacy and safety of its investigational drug vericiguat, an orally administered soluble...

at 10:00
Amgen today announced positive results from the EvolocumaB Effect on LDL-C LowerIng in SubJEcts with Human Immunodeficiency ViRus and INcreased Cardiovascular RisK (BEIJERINCK) study evaluating the efficacy and safety of Repatha® (evolocumab) in...



News published on 26 march 2020 at 23:20 and distributed by: